366 related articles for article (PubMed ID: 6744274)
1. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
2. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
Kugoh HM; Hashiba H; Shimizu M; Oshimura M
Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
5. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
6. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
[TBL] [Abstract][Full Text] [Related]
7. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids.
Srivatsan ES; Benedict WF; Stanbridge EJ
Cancer Res; 1986 Dec; 46(12 Pt 1):6174-9. PubMed ID: 2877730
[TBL] [Abstract][Full Text] [Related]
8. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenicity of a human lung carcinoma line by nontumorigenic bronchial epithelial cells in somatic cell hybrids.
Kaighn ME; Gabrielson EW; Iman DS; Pauls EA; Harris CC
Cancer Res; 1990 Mar; 50(6):1890-6. PubMed ID: 2306741
[TBL] [Abstract][Full Text] [Related]
10. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal radiosensitivity during the G2 cell cycle period and cytopathology of human normal x tumor cell hybrids.
Sanford KK; Parshad R; Stanbridge EJ; Frost JK; Jones GM; Wilkinson JE; Tarone RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2045-9. PubMed ID: 3948180
[TBL] [Abstract][Full Text] [Related]
12. Expression of malignancy in hybrids between normal and malignant cells.
Croce CM; Barrick J; Linnenbach A; Koprowski H
J Cell Physiol; 1979 Jun; 99(3):279-85. PubMed ID: 457790
[TBL] [Abstract][Full Text] [Related]
13. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
[TBL] [Abstract][Full Text] [Related]
14. Modification of myc gene amplification in human somatic cell hybrids.
Iman DS; Shay JW
Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
[TBL] [Abstract][Full Text] [Related]
15. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes.
Geiser AG; Anderson MJ; Stanbridge EJ
Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenicity and induction of senescence on human endometrial carcinoma cell lines by transfer of normal human chromosomes.
Yamada H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1443-54. PubMed ID: 7705753
[TBL] [Abstract][Full Text] [Related]
18. Selective incorporation of fibronectin isoforms into the extracellular matrix of hybrids between human fibrosarcoma cells and normal human fibroblasts.
Devlin J; Harris H
Exp Cell Res; 1994 Sep; 214(1):429-32. PubMed ID: 8082745
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of human fibroblasts by a transfected N-ras oncogene.
Wilson DM; Yang DJ; Dillberger JE; Dietrich SE; Maher VM; McCormick JJ
Cancer Res; 1990 Sep; 50(17):5587-93. PubMed ID: 2201439
[TBL] [Abstract][Full Text] [Related]
20. Loss of the intrinsic heat resistance of human cells and changes in Mr 70,000 heat shock protein expression in human x hamster hybrids.
Anderson RL; Fong KJ; Gabriele T; Lavagnini P; Hahn GM; Evans JW; Waldren CA; Stamato TD; Giaccia AJ
Cancer Res; 1991 May; 51(10):2636-41. PubMed ID: 2021941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
